Phase II Study of Trabectedin as Salvage Chemotherapy in Patients With Metastatic Adenocarcinoma of the Pancreas Whose Disease Progressed After Gemcitabine-Containing First-Line Chemotherapy .
28 abril 2011
Yondelis inicia Fase II para Tratar Cáncer de Pancreas , se realizara en Italia bajo la Supervisión del NCI y del Hospital San Rafael de Milan .
Phase II Study of Trabectedin as Salvage Chemotherapy in Patients With Metastatic Adenocarcinoma of the Pancreas Whose Disease Progressed After Gemcitabine-Containing First-Line Chemotherapy .